Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.27
-0.17 (-0.48%)
Jun 12, 2026, 4:00 PM EDT - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 12.01%, UnitedHealth Group at 5.70%, Novo Nordisk at 5.08%, Roche Holding AG at 4.39%, and Merck & Co. at 4.34%.
Total Holdings
46
Top 10 Percentage
49.76%
Asset Class
Equity
ETF Category
Health
Assets
51.59M
PE Ratio
20.35
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.01% |
| 2 | UNH | UnitedHealth Group Incorporated | 5.70% |
| 3 | CPH: NOVO.B | Novo Nordisk A/S | 5.08% |
| 4 | RHHBY | Roche Holding AG | 4.39% |
| 5 | MRK | Merck & Co., Inc. | 4.34% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 3.94% |
| 7 | LON: AZN | AstraZeneca PLC | 3.93% |
| 8 | JNJ | Johnson & Johnson | 3.85% |
| 9 | SWX: NOVN | Novartis AG | 3.38% |
| 10 | GILD | Gilead Sciences, Inc. | 3.15% |
| 11 | RVMD | Revolution Medicines, Inc. | 3.09% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.89% |
| 13 | ABT | Abbott Laboratories | 2.75% |
| 14 | DHR | Danaher Corporation | 2.71% |
| 15 | BBIO | BridgeBio Pharma, Inc. | 2.68% |
| 16 | ABBV | AbbVie Inc. | 2.51% |
| 17 | CYTK | Cytokinetics, Incorporated | 2.24% |
| 18 | MDT | Medtronic plc | 2.07% |
| 19 | BMY | Bristol-Myers Squibb Company | 2.06% |
| 20 | TEVA | Teva Pharmaceutical Industries Limited | 1.99% |
| 21 | DXCM | DexCom, Inc. | 1.97% |
| 22 | AMGN | Amgen Inc. | 1.94% |
| 23 | MCK | McKesson Corporation | 1.84% |
| 24 | EW | Edwards Lifesciences Corporation | 1.76% |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 1.65% |
As of Jun 10, 2026